-
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
19 Feb 2026 12:00 GMT
… sciences companies, equity research, and investment banking. As Chief Financial Officer … and strategic finance roles at Forest Laboratories, Inc. and Regeneron Pharmaceuticals, … by applicable law. Investor and Media Relations:
Investors:
Jason Awe, PhD …
-
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
17 Feb 2026 12:00 GMT
… and Chief Scientific Officer of Forest Laboratories and held senior clinical research … a past board member of Forest Laboratories, Ironwood Pharmaceuticals, Axovant Sciences Ltd … Litigation Reform Act of 1995. Investor & Media Relations:
IR@cyclerion …
-
AbbVie Deal Crowns 25 Years of Determination: Glenn Saldanha
13 Feb 2026 17:44 GMT
… -licensing deals, starting with Forest Laboratories in 2004, followed by … company faced numerous setbacks. “Investors were often not aligned with … , so we committed to investing in it ourselves. Midway, … sustained R&D investment, shifting the focus from …
-
<![CDATA[European Biotechs Impacting Treatment of Alzheimer’s Disease]]>
12 Feb 2026 18:16 GMT
… AD treatments, such as Forest Laboratories' orally active Namenda … are the pharma industry investing in?
At present, … align drug development and investment in innovative medicines for … SR One, alongside existing investors M Ventures, Sofinnova Partners, …
-
Memantine HCl Market Analysis 2025 – Insights For Long-Term Investment & Planning
01 Jul 2025 12:32 GMT
The Business Research Company’s Memantine HCl Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, July 1, 2025 /EINPresswire.com/ -- Save 30% On All Global Market Reports With …
-
Polaryx Therapeutics Welcomes New Members of the Board of Directors
05 Feb 2026 13:30 GMT
… ; Co. L.P., a global investment firm, since July 2024, a … Chief Intellectual Property Counsel at Forest Laboratories (now AbbVie) for more than … ) 655-0924
Julesa@coreir.com
Investor Contacts:
CORE IR
(212) 655 …
-
Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 Stocks
17 Mar 2025 19:58 GMT
… investor, investing in well-known names such as Biogen (NASDAQ:BIIB) and Forest Laboratories … About This Article:
Billionaire healthcare investor Alex Denner’s Sarissa Capital … per stock.
Considering some billionaire investor hedge funds, that’s not …
-
Global Substance Abuse Treatment Market Report to 2030 - Featuring Alkermes, Allergan, Forest Laboratories and GlaxoSmithKline Among Others
30 Jan 2023 10:25 GMT
… key players and attractive investment proposition provide the readers …
What are the key investment pockets with respect to … and middle-income economies investing in the Substance Abuse … 4. Strategic Initiatives
10.3. Forest Laboratories, Inc.
10.3.1. …
-
Global Angina Pectoris Treatment Market Report 2022 to 2030 - Featuring Forest Laboratories, Gilead Sciences, GlaxoSmithKline, Novartis and Pfizer Among Others - ResearchAndMarkets.com
31 Jan 2023 14:56 GMT
…
F. Hoffmann-La Roche Ltd.
Forest Laboratories Inc.
Gilead Sciences, Inc.
GlaxoSmithKline … market?
What are the key investment pockets with respect to product … low and middle-income economies investing in the Angina Pectoris Treatment …
-
Biogen Appoints Chuck Triano as Head of Investor Relations
14 Mar 2023 12:39 GMT
… the Vice President of Investor Relations at Forest Laboratories, where he initiated the … pipeline programs; capital allocation and investment strategy. These forward-looking … rate fluctuations; risks relating to investment in our manufacturing capacity; …
About
© 1995-2026